HomeMOLDTECH › Filing
🔔 Get instant alerts when MOLDTECH files quarterly results on BSE Start free trial →

Outcome of the Board Meeting

Filed: 06 Aug 2026, 14:08 IST Exchange: BSE Category: Financial Results — Audited Results
Q1FY27 results (unaudited): Standalone: Revenue 0.455bn +56% y-y (0.291bn) EBITDA 0.149bn +537% y-y (0.023bn) EBITDA margin 32.8% (8.0%) +2480 bps y-y PAT 0.100bn +1603% y-y (0.006bn) Consolidated: Revenue 0.595bn +79% y-y (0.333bn) EBITDA 0.139bn +470% y-y (0.024bn) EBITDA margin 23.3% (7.0%) +1630 bps y-y PAT 0.090bn +1215% y-y (0.007bn) Commentary: The company delivered its highest-ever quarterly revenue, EBITDA and PAT driven by strong execution, business diversification, and U.S. expansion including integration of the U.S. subsidiary Beryl Project Engineering LLC, which expanded service offerings and market presence.
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 MOLDTECH — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add MOLDTECH to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Mold-Tek Technologies Limited

Important. The summary above is generated automatically from Mold-Tek Technologies Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.